François Fournier named President & CEO of Virbac North America
01/16/2019
Virbac announces François Fournier’s appointment as President & CEO of Virbac North America, effective January 7, 2019. His main mission is to lead and develop all North American Virbac activities, in line with the Virbac Group’s global strategy.
New Dental Chew Does More Than Just Freshen Breath by Supporting Proper Digestion in Dogs
07/10/2018
Virbac Corporation has announced the launch of C.E.T.® VEGGIEDENT® FR3SH® Tartar Control Chews for Dogs, which uniquely targets bad breath while supporting proper digestion.
New FDA-Approved Bacon-Flavored Chew Represents a First in Heartworm and Internal Parasite Protection
05/17/2018
Virbac Corporation has announced the launch of IVERHART MAX® (ivermectin/pyrantel pamoate/praziquantel) Soft Chew, the newest addition to its IVERHART® Brand portfolio and the only ivermectin-based, bacon-flavored...
Virbac Corporation Announces Eric Bonner as Vice President of Industrial Operations
04/06/2018
Virbac Corporation today announced that Mr. Eric Bonner has been named Vice President of Industrial Operations.
Virbac Corporation Designated First Blue Zones Project Approved™ Worksite in North Fort Worth
10/25/2017
Fort Worth, Texas (October 23, 2017) – Virbac Corporation is thrilled to announce its designation as the newest Blue Zones Project ApprovedTM worksite in Fort Worth. Virbac Corporation is one of the largest independent veterinary pharmaceutical companies in the world, and the U.S. headquarters are based in Fort Worth. This marks the first North Fort Worth organization to receive the designation.
